International Cannabis Weekly: 271

90% OF TICKETS NOW SOLD FOR BUSINESS OF CANNABIS: NEW YORK

There’s just one week to go until business leaders descend upon the New York Academy of Medicine for a special day-long program of New York state policy makers, prominent investors and industry executives. 90% of tickets have now been sold – secure your seat today.

The New York cannabis market is about to explode and momentum is building as businesses try to navigate this newly legal state. Business of Cannabis: New York will explore everything from regulation to investment, licensing to social equity – and everything in between.

Connect and collaborate with industry leaders on 3 November. Get your tickets today before they sell out imminently.

BUY NOW »

GERMANY SET TO BECOME EUROPE’S LARGEST LEGAL CANNABIS MARKET

READ MORE »

BIDEN SAYS CANNABIS PARDONS WILL NOT EXTEND TO THOSE WHO SOLD CANNABIS

READ MORE »

• The European Commission still has to give the green light for new German legislation.
• Inflammatory bowel disease patients report improvements with medical cannabis in a new study.
• Hemp could be the solution to delivering growth in agriculture and boost the UK economy.
• The regional council in Calabria has unanimously approved the regional law on dispensing medical cannabis.
• Medicinal cannabis dispensing on the Isle of Man has been further delayed over technical issues.
• Dutch growers who have been selected to take part in the governments cultivation trials have been delayed.
• High-THC cannabis flower has been linked to improvements in quality of life and reducing anxiety.
• French MP has tabled an amendment to the social security bill to relaunch the debate on cannabis legalisation.
• Growing hemp has proved successful in removing harmful chemicals from topsoil and purifying polluted water.
• SynBiotic has seen a 15% increase in its stock price this week, helping rescue its share price from historic lows.

• The State Health Department stated that Florida hasn’t approved a deal between Circle K and Green Thumb Industries.
• Cannabis leaders and politicians are set to join forces at Business of Cannabis: New York.
• Researchers at a Miami university have found that CBD has heavy metals and plastic contaminants.
• The ASA has issued its 2022 Vote Medical Marijuana voter guide in a bid to educate supporters.
• AFC Gamma, Inc. has amended its previously announced US$100 million credit facility with Acreage Holdings.
• Washington D.C medical cannabis patient registrations continue to surge since the self-certification law.
• Curaleaf expands its portfolio with the launch of Find Cannabis Flower, stocked in dispensaries in Massachusetts.
• A national animal food group is urging Idaho officials to delay a ban on animal foods that contain hemp.
• US basketball player Brittney Griner has an appeal rejected by the Moscow court after a cannabis conviction.
• South Dakota is one of five states that will vote on legalising adult-use cannabis this November.

CANNABIS EUROPA LONDON RETURNS ON 2-3 MAY 2023

Cannabis Europa 2023 will be returning to The Barbican Centre for our industry leading conference. We will once again be holding a boutique industry expo, showcasing more than 50 leading businesses as the cream of the European cannabis crop, acting as a jumping-off point for growing your business in Europe and beyond.

Join 1,500 leaders from thriving cannabis companies, investors actively deploying capital into the market, plus key politicians – a crucial combination to drive your business forward and to navigate this ever-changing field.

Book your place for 2-3 May 2023 now – join the global industry in London to set the framework for cannabis going mainstream across Europe.

BUY YOUR TICKET »

• Delta 9 Cannabis has won Manitoba’s first cannabis distributor licence from the LGCA.
• Canopy Growth has created a holding company designed to enable it to fast-track entry into the US market.
• Flora Growth signs a definitive agreement to acquire Franchise Global Health, a medical cannabis distributor.
• CBD company Craft 1861 Global is set to go public through its merger with BGP Acquisition Corp.
• High Tide has opened its third Canna Cabana store in Vancouver, British Columbia.
• BYND cannasoft Enterprises announces its agreement with Globus Pharma to distribute medical cannabis.

• The CFM in Brazil has temporarily suspended the resolution that would restrict doctors prescribing cannabis.
• Training has taken place for the security forces in Argentina on the law around cannabis and its therapeutic uses.
• The Argentine National Service for Agrifood Health has held a closed meeting on the development of cannabis.
• The state in Argentina has opened up a tender to acquire 3,000 bottles of cannabidiol for epilepsy treatment.

• ECS Botanics Holdings Ltd has announced it has offloaded its Tasmanian business and assets.
• Cann Group is aiming to raise another A$10 million via a share purchase plan to expand its manufacturing capabilities.
• Wellnex Life has raised A$5 million in investment as it looks to dominate the Australian medical cannabis market.
• Kyung Hee University Medical Centre is set to conduct a study on the effectiveness of medical cannabis.
• Hong Kong is set to ban CBD, with up to 7 years in jail for possession to match heroin and cocaine.
• Over 1,000 clinics offering cannabis-based treatments have opened since the start of the year in Thailand.

If you haven’t already, then download the Asian Cannabis Report: 2nd Edition to get insight into the evolution – and future trajectory – of the cannabis industry in Asia.

To complement the report, we have two premium packages available. The first is Prohibition Partners’ proprietary market sizing data, which includes country-by-country forecasts of the medical, CBD and adult-use cannabis markets in Asia. Market sizing forecasts are provided for countries in Asia, including: Japan, Taiwan, South Korea, Thailand, India, Malaysia, Nepal and Sri Lanka.

The second package is a 20-page guide entitled Business Insights into the Thai Cannabis Market. Both can be purchased for £990, saving you £90.

SEE PREMIUM PACKAGES »

• An Israeli company has cloned hemp cells and used a bioreactor to grow cannabis with 12 times the potency.
• ZIDA has called upon investors to inject funds into the Zimbabwe medicinal cannabis sector for growth.
• MediCane has announced the first patient has been enrolled in its clinical trial to reduce the symptoms of dementia.